Bioject Medical Technologies RSS Feed | Nachrichten - www.finanzen.net

Bioject Reports Second-Quarter 2008 Financial Results

Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free drug delivery systems, today reported financial results for the second quarter ended June 30, 2008. Bioject reported revenues of $1.7 million ...

Bioject to Report Second Quarter 2008 Financial Results

Bioject Medical Technologies Inc., (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, announced today that the Company will report its financial results for the second quarter ended June 30, 2008 on Wednesday, ...

Bioject to Be Transferred to the over-the-Counter Bulletin Board

Bioject Medical Technologies Inc. (NASDAQ:BJCT), a leading developer of needle-free injection therapy systems, today announced that it has received notification from The Nasdaq Stock Market LLC that ...

Biojector(R)2000 Data Presented in Vical's Pandemic Influenza DNA Vaccine Human Trial

Bioject Medical Technologies Inc. (Nasdaq: BJCT), a leading developer of needle-free injection therapy systems, today announced that the Biojector� 2000 (B2000) was used in Vical Inc.�s (Vical) first Phase 1 human trial of H5N1 pandemic ...

Bioject Announces Long-Term Agreement with Merial Limited

Bioject Medical Technologies Inc. (Nasdaq:BJCT) ("Bioject�), a leading developer of needle-free injection therapy (NFIT) systems, today announced that it has signed a new long-term exclusive license, development and supply agreement ...

Bioject and ImmunoVaccine Technologies Announce Research Collaboration

Bioject Medical Technologies Inc. (Nasdaq: BJCT), a leading developer of needle-free injection therapy (NFIT) systems, and ImmunoVaccine Technologies, Inc. (IVT), a vaccine development company, today announced they have entered into ...

Bioject Medical Technologies Inc. Annual Shareholders' Meeting Thursday, June 5, 2008

Bioject Medical Technologies Inc., (Nasdaq:BJCT), a leading developer of needle-free injection therapy systems, announced today that the Company will hold its Annual Shareholders� Meeting on Thursday, June 5, 2008 at 9:00 a.m. Pacific ...

Biojector(R)2000 Technology Put to the Test in CDC Flu Vaccine Study

Bioject Medical Technologies Inc. (Nasdaq:BJCT), a leading developer of needle-free injection therapy ("NFIT�) systems, today announced that the Biojector�2000 ("B2000�) needle-free system has advanced to Phase II in a clinical ...

Bioject Receives Nasdaq Staff Determination

Bioject Medical Technologies Inc. (NASDAQ:BJCT), a leading developer of needle-free injection therapy systems, today announced that, as anticipated, on May 20, 2008, the Company received a letter from the Listing Qualifications Staff ...

Bioject Reports First Quarter 2008 Financial Results

Bioject Medical Technologies Inc. (Nasdaq: BJCT), a leading developer of needle-free drug delivery systems, today reported financial results for the quarter ended March 31, 2008. For the quarter ended March 31, 2008, Bioject ...